DE93942C - - Google Patents
Info
- Publication number
- DE93942C DE93942C DENDAT93942D DE93942DA DE93942C DE 93942 C DE93942 C DE 93942C DE NDAT93942 D DENDAT93942 D DE NDAT93942D DE 93942D A DE93942D A DE 93942DA DE 93942 C DE93942 C DE 93942C
- Authority
- DE
- Germany
- Prior art keywords
- acid
- gallic acid
- properties
- water
- benzoyl chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 18
- 229940074391 gallic acid Drugs 0.000 claims description 9
- 235000004515 gallic acid Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012670 alkaline solution Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
DE93942C true DE93942C (enrdf_load_stackoverflow) |
Family
ID=365332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT93942D Active DE93942C (enrdf_load_stackoverflow) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE93942C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT93942D patent/DE93942C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2228012C3 (de) | Phthalidester der 6- [D(-)- a Aminophenylacetamido] -penicillansäure und Verfahren zu seiner Herstellung | |
DE19843413C1 (de) | Neue Salzform von Pantoprazol | |
DE4018642C2 (de) | Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes | |
DE68922218T2 (de) | Kontrastmittel für magnetische resonanzabbildung des kleinen darms und des hepatobiliaren systems. | |
DE93942C (enrdf_load_stackoverflow) | ||
DE2805224A1 (de) | Verfahren zur erzeugung der aktiven substanz eines antilithiaticums, das antilithiaticum und dessen anwendung zur behandlung von nierensteinleiden | |
DE117767C (enrdf_load_stackoverflow) | ||
DE187869C (enrdf_load_stackoverflow) | ||
DE1493513C3 (de) | Sulfamylanthranilsäuren, deren therapeutisch verwendbare Salze, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen Präparate | |
DE189838C (enrdf_load_stackoverflow) | ||
DE926489C (de) | Verfahren zur Gewinnung eines neuen kristallisierten Glukosids der Herbstzeitlose, Colchicosid genannt | |
DE2244179C3 (de) | D-threo-l-p-substituierte Phenyl-2dichloracetamidopropan-I.S-diol-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE259193C (enrdf_load_stackoverflow) | ||
DE87670C (enrdf_load_stackoverflow) | ||
DE518208C (de) | Verfahren zur Herstellung von Acylaminobenzolstibinsaeuren | |
DE1443297C3 (de) | 20.07.61 USA 125373 5-Amino-2,4,6-trijodisophthalamidsäurederivate Verfahren zu ihrer Herstellung und diese enthaltende Röntgenkontrastmittel Mallinckrodt Chemical Works, St. Louis, Mo. (V.St.A.) | |
DE364883C (de) | Verfahren zur Herstellung von Mitteln gegen Eingeweidewuermer | |
DE948735C (de) | Verfahren zur Gewinnung eines therapeutisch wirksamen Stoffes aus Organismen der Klasse Crustacea und Myriapoda | |
DE286854C (enrdf_load_stackoverflow) | ||
DE218478C (enrdf_load_stackoverflow) | ||
DE106496C (enrdf_load_stackoverflow) | ||
DE129255C (enrdf_load_stackoverflow) | ||
DE2144679A1 (de) | Verfahren zur Gewinnung eines Doxyzyklinsalzes | |
DE212422C (enrdf_load_stackoverflow) | ||
DE1643520A1 (de) | Neue kapillarschuetzende und antiinflammatorische Mittel |